Drugs Market Research Reports & Industry Analysis

... testing, oral testing and hair testing. Renub Research report titled “Drug of Abuse Testing Market Global Forecast by Products (Consumable, Equipment - Immunoassay Analyzers, Breath Analyzers), Test Types (Urine, Blood, Oral, Hair), End Users/Setting Types ...

... 2. General Intravenous Anesthesia Propofol Benzodiazepines Class Fospropofol Disodium Ketamine Methohexital Sodium Pentobarbital Etomidate Fentanyl 3. Local Anesthesia Articaine Bupivacaine Lidocaine Mepivacaine Prilocaine Key Players Sales - United States Anesthetic Drugs Market 1. Baxter International Inc ...

... the growth of United States Generic Drugs Market in the near future. Renub Research report titled “United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology ...

... of antibiotic of a single drug is improved. Market Analysis: The “Global Bacterial Conjunctivitis Drugs Market” is estimated to witness a CAGR of 2.1% during the forecast period 2018–2024. The bacterial conjunctivitis drugs market is analyzed based on two ...

... research report categorizes the antiulcerant drugs market by type, including proton pump inhibitors, H2 receptor antagonists, gastric mucosal protective drugs, antibiotics, antacids and ... 3D printing and IoT in the growth of the antiulcerants drugs market Coverage of definition, types, causes, and treatment ...

... needs of society and awareness towards leading a healthy life. The Europe chronic idiopathic constipation drug market is estimated to grow at a CAGR of 8.96% during ... in this market. COMPETITIVE INSIGHTS Major players in the Europe CIC drug market include Progenics Pharmaceuticals Inc, Theravance Biopharma Inc ...

KEY FINDINGS Global Chronic Idiopathic Constipation drug market is estimated to grow at a CAGR ... growth opportunities. REGIONAL INSIGHTS Geographically, the global CIC drug market is segmented four major regions ... adopted by the various market players of global CIC drug market. The other strategies include ...

KEY FINDINGS The North America Chronic Idiopathic Constipation Drug Market is expected to grow at a CAGR of 6.95% over the forecast period. ... some of the factors driving the market MARKET INSIGHTS The North America chronic idiopathic constipation drug market is segmented on the basis of drug types and on the ...

KEY FINDINGS The Asia Pacific ophthalmic drugs and devices market holds ... , with the shift of clinical activities to Asia Pacific region. The Asia-Pacific region has extremely assorted healthcare systems; each ... Major factors which are driving the ophthalmic drug market in China include the rising geriatric ...

... led to the increased trust in the drugs market, which is a key factor driving growth in the Europe ophthalmology drug and devices market. By the end of the ... ageing population. On the other hand, it is the Russian ophthalmic drugs and devices market that is anticipated to exhibit the highest CAGR over the ...

... . Propelled by these factors, the global Antithrombotic drugs market is anticipated to evolve further at a CAGR of 6.83% over the forecast period of 2018-2026. MARKET INSIGHTS The antithrombotic drug market is segmented on the basis ...

... of awareness among people regarding ophthalmology. REGIONAL INSIGHTS Geographically, the global ophthalmic drugs & devices market is segmented into North America, Europe, Asia-Pacific ...

... among all age group, gender and racial group in North America. As a result, the North America ophthalmic drugs and devices market is expected to progress at a CAGR of ... . Increasing pharmaceuticals market is the key driver for the US ophthalmic drug market. Also, as the prevalence of eye disorders in the US is ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Constipation pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Diabetic gastroparesis pipeline product. Mechanism of Action ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Diarrhea pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Dyspepsia pipeline product. Mechanism of Action and ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Enterocolitis pipeline product. Mechanism of Action and ...

... 15 companies and universities are focusing on developing treatment options for Eosinophilic Esophagitis. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Eosinophilic Esophagitis pipeline product. ...

... universities are focusing on developing treatment options for Exocrine Pancreatic Insufficiency. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Exocrine Pancreatic Insufficiency pipeline product. ...

Gastritis is the inflammation of mucosa, lining of stomach, that can last for shorter periods or longer durations. Infection, alcohol and intake of NSAIDs lead to gastritis. ... /IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other ...

... Gastroesophageal Reflux Disease (GERD). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Gastroesophageal Reflux Disease (GERD ... the report provides key trends in Gastroesophageal Reflux Disease (GERD) pipeline studies. The products under ...

... billion market in the US alone, Hepatic Encephalopathy is a GI disorder affecting around 2 million people in the country. Hepatic Encephalopathy (HE) is a neuropsychiatric syndrome with ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatic Encephaopathy ...

... 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding and ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) pipeline product ...

... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Irritable Bowel Syndrome pipeline product. Mechanism of Action ...

... Over 20 companies and universities are focusing on developing treatment options for Liver Cirrhosis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Cirrhosis pipeline product. ...

... Over 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) ...

... Opioid Induced Constipation (OIC). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Opioid Induced Constipation (OIC ... , the report provides key trends in Opioid Induced Constipation (OIC) pipeline studies. The products under development ...

... Over 30 companies and universities are focusing on developing treatment options for Oral Mucositis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Oral Mucositis pipeline product. ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Pancreatitis pipeline product. Mechanism of Action and ...

... Over 20 companies and universities are focusing on developing treatment options for Peptic Ulcers. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peptic Ulcers pipeline product. Mechanism ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peritonitis pipeline product. Mechanism of Action and ...

... companies and universities are focusing on developing treatment options for Post Operative Nausea and Vomiting. To assist investigators and funding and regulatory ... , VPA Research has come up with a comprehensive report on Post Operative Nausea and Vomiting pipeline. The report provides insights into different ...

... and universities are focusing on developing treatment options for Primary biliary cirrhosis. To assist investigators and funding and regulatory organizations, ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary biliary cirrhosis pipeline product. Mechanism ...

... universities are focusing on developing treatment options for Primary billary cholangitis. To assist investigators and funding and regulatory organizations ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary billary cholangitis pipeline product. Mechanism ...

... universities are focusing on developing treatment options for Primary sclerosing cholangitis. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Primary sclerosing cholangitis pipeline product. Mechanism ...

... Around 30 companies and universities are focusing on developing treatment options for Reflux Esophagitis/GERD. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Reflux Esophagitis/GERD pipeline product. ...

... and universities are focusing on developing treatment options for Short Bowel Syndrome. To assist investigators and funding and regulatory organizations, ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Short Bowel Syndrome pipeline product. Mechanism of ...

... Around 15 companies and universities are focusing on developing treatment options for Systemic Mastocytosis. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Systemic Mastocytosis pipeline product. ...

... Around 10 companies and universities are focusing on developing treatment options for Traveler's Diarrhea. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Traveler's Diarrhea pipeline product. ...

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Thousand. The report provides separate comprehensive analytics for the US, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

The 2018 U.S. Drugs and Druggists' Sundries ... 2018 current and 2019 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States ... sub-industries, including special line drugs and general line drugs. This industry comprises establishments primarily ...

... and universities are focusing on developing treatment options for Alcoholic Hepatitis. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Alcoholic Hepatitis pipeline product. ...

... and universities are focusing on developing treatment options for Atrial Fibrillation. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Atrial Fibrillation pipeline product. ...

... , neurological conditions. Celiac Disease pipeline comprises of 24 active drugs under active development as of April 2018. Of these, 4 drugs are in Phase 1 and 4 drugs in phase 2. None of the drugs have progressed ...

... companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Colitis pipeline product. Mechanism of Action and ...

... myalgia, arthralgia are key symptoms. Community Acquired Pneumonia pipeline comprises of 16 drugs under active development as of April 2018. Of these, 3 drugs are ... has come up with a comprehensive report on Community Acquired Pneumonia (CAP) pipeline. The report provides insights into different therapeutic ...

... Critical Limb Ischemia worldwide, with an estimated market size of $10 to $12 billion. Critical Limb Ischemia pipeline comprises of 27 active drugs under active development as of April 2018 ... come up with a comprehensive report on Critical Limb Ischemia (CLI) pipeline. The report provides insights into ...

... no vaccine is available against HCV. Due to the mutations in Hepatitis C virus, development of a prophylactic vaccine is highly challenging. The condition is classified ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatitis C (HCV) pipeline ...